Introduction:
Severe Acute Respiratory Syndrome -Coronavirus 2 (SARS-COV2) was
responsible for the latest outbreak recently, presenting as mainly
respiratory symptoms and carrying high mortality rate[1]. COVID-19
put all people at risk of being infected including haemoglobinopathies
patients. Multiple factors among those patients increase their risk for
infections yet the occurrence of reinfection and it is implication on
them, and the community were not described before. Thalassemia is one of
the most common haemoglobinopathies and requires life-long management
and follow up. Splenectomy, regular blood transfusion and iron chelation
therapy are essential components in the management plan. Unfortunately,
they cause some complications on the long term and might raise the
slurpability of current reinfection[2]. The impact of these factors
on COVID-19 infection is not well known yet.
Here we present a case of 31-year-old splenectomized lady with
transfusion dependent Beta Thalassemia Major had COVID-19 infection
recurrence detected by screening. In this article we are discussing the
possibility behind COVID-19 reinfection in thalassemia patients.